Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | 1.23% | 89.07 | 1.3% | $885.86m | |
| AMGN | Amgen Inc. | 0.09% | 191.49 | 1.2% | $554.58m | |
| GILD | Gilead Sciences, Inc. | 0.72% | 65.49 | 0.9% | $453.28m | |
| ONCE | Spark Therapeutics, Inc. | -0.25% | 113.67 | 11.2% | $443.24m | |
| BIIB | Biogen Inc. | -0.58% | 323.76 | 1.3% | $352.26m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.15% | 406.99 | 2.6% | $278.79m | |
| ILMN | Illumina, Inc. | 1.61% | 310.70 | 3.5% | $273.06m | |
| BPTH | Bio-Path Holdings, Inc. | -9.32% | 25.20 | 190.1% | $257.65m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -3.05% | 181.76 | 1.9% | $239.61m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.28% | 126.47 | 15.4% | $205.98m | |
| EXAS | Exact Sciences Corporation | -0.85% | 91.15 | 25.3% | $189.71m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.43% | 132.94 | 2.0% | $178.02m | |
| A | Agilent Technologies, Inc. | 0.28% | 81.20 | 1.6% | $151.29m | |
| IONS | Ionis Pharmaceuticals, Inc. | 0.11% | 79.61 | 8.3% | $101.25m | |
| BMRN | BioMarin Pharmaceutical Inc. | -2.06% | 91.44 | 4.3% | $95.59m |
Company Profile
Illumina, Inc. engages in the development and manufacture of integrated systems for the analysis of genetic variation and function. It operates through the Core Illumina and Consolidated Variable Interest Entity segments (VIE). The Core Illumina segments serve customers in the research, clinical and applied markets, and enable the adoption of genomic solutions. The Consolidated VIE segment includes activities of GRAIL and Helix. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.